Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it secured $100 million in Series C funding.
Alpha Wave Ventures led the round with participation from existing investors AXA IM Alts, M Ventures, LifeSci Venture Partners, RiverVest Venture Partners, Hikma Ventures, Taisho Pharmaceutical, Features Capital and Aphelion...
In a head-to-head comparison of sensor-augmented insulin pumps, the touchscreen device from Tandem Diabetes Care outperformed that from Medtronic, according to new data presented at the Annual Advanced Technologies and Treatments for Diabetes conference in Paris.
The self-reported data from San Diego-based Tandem comes from a retrospective study analyzing de-identified data from 3,046 Tandem SAP...
